NASDAQ:VBIV

VBI Vaccines Insider Trades

$2.90
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.85
Now: $2.90
$3.05
50-Day Range
$2.74
MA: $3.17
$3.62
52-Week Range
$1.02
Now: $2.90
$6.93
Volume2.44 million shs
Average Volume6.62 million shs
Market Capitalization$735.34 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14

Insider Trades

VBI Vaccines (NASDAQ:VBIV) Insider Buying and Selling Activity

Insider Ownership Percentage: 10.50%
Insider Buying (Last 12 Months): $10,999,999.89
Insider Selling (Last 12 Months): $0.00

Insider Buying and Selling by Quarter


VBI Vaccines (NASDAQ VBIV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/24/2020Life Sciences Maste PerceptiveMajor ShareholderBuy9,090,909$1.21$10,999,999.89  
10/4/2019Francisco Diaz-MitomaInsiderBuy40,000$0.50$20,000.00268,839  
10/1/2019Christopher McnultyCFOBuy12,000$0.47$5,640.0037,000  
10/1/2019Nell BeattieInsiderBuy10,000$0.48$4,800.0060,000  
9/30/2019Jeff BaxterCEOBuy150,000$0.50$75,000.00608,255  
9/23/2019Perceptive Advisors LlcMajor ShareholderBuy20,000,000$0.50$10,000,000.00  
9/19/2019Steven GillisDirectorBuy10,000,000$0.50$5,000,000.00
6/27/2019Francisco Diaz-MitomaInsiderBuy8,000$1.07$8,560.00268,839  
6/19/2019Jeff BaxterCEOBuy144,000$0.73$105,120.00458,255  
6/19/2019Nell BeattieInsiderBuy8,000$0.74$5,920.0050,000  
6/17/2019Life Sciences Maste PerceptiveMajor ShareholderBuy1,000,000$0.62$620,000.00  
12/17/2018Tomer KarivDirectorBuy1,428,571$1.40$1,999,999.40  
12/13/2018Perceptive Advisors LlcMajor ShareholderBuy14,285,714$1.40$19,999,999.60  
8/6/2018Jeff BaxterCEOBuy8,100$1.93$15,633.00233,005  
8/3/2018Jeff BaxterCEOBuy13,500$2.01$27,135.00224,905  
8/3/2018Nell BeattieInsiderBuy2,000$2.01$4,020.0020,750  
7/31/2018Jeff BaxterCEOBuy16,800$2.28$38,304.00211,405  
5/24/2018Jeff BaxterCEOBuy11,000$2.99$32,890.00163,355  
5/11/2018Francisco Diaz-MitomaInsiderBuy10,000$3.05$30,500.00268,839  
5/11/2018Jeff BaxterCEOBuy7,100$2.91$20,661.00152,355  
12/12/2017Jeff BaxterCEOBuy10,000$3.89$38,900.00140,646  
11/28/2017Jeff BaxterCEOBuy15,000$4.75$71,250.00135,255  
10/30/2017Opko Health, Inc.Major ShareholderBuy655,738$3.05$2,000,000.90  
10/30/2017Steven GillisDirectorBuy300,000$3.05$915,000.0046,916  
10/26/2017Life Sciences Maste PerceptiveMajor ShareholderBuy3,100,000$3.05$9,455,000.00  
8/21/2017Francisco Diaz-MitomaInsiderBuy3,000$3.17$9,510.00264,339  
8/21/2017Jeff BaxterCEOBuy10,000$3.22$32,200.00120,255  
8/10/2017Jeff BaxterCEOBuy10,000$3.28$32,800.00110,255  
12/6/2016Perceptive Advisors LlcMajor ShareholderBuy3,383,955$3.05$10,321,062.75  
8/14/2015Perceptive Advisors LlcMajor ShareholderBuy650,000$2.08$1,352,000.00  
9/30/2013Murray George SmithCFOBuy3,027$1.13$3,420.51  
8/21/2013Murray George SmithCFOBuy8,973$1.17$10,498.41  
(Data available from 1/1/2013 forward)
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.